Remove tag day-one-biopharmaceuticals
article thumbnail

Drug-resistant epilepsy drug Ontozry backed by NICE

pharmaphorum

It is recommended only if it is used as an add-on treatment, after at least one other add-on treatment has not controlled seizures, and treatment is started in a tertiary epilepsy service. Focal onset seizure is a type of epilepsy in which seizures start in one side of the brain, acconting for around 60% of all epilepsy cases.

article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. Keeping our patients’ needs first, our global manufacturing facilities are now operating 24 hours, seven days a week, and we have invested approximately $1.6 Free Report.

Insurance 105
article thumbnail

The “Medical Bypass”: new drugs to strike obesity

Pharmaceutical Technology

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. Keeping our patients’ needs first, our global manufacturing facilities are now operating 24 hours, seven days a week, and we have invested approximately $1.6 Free Report.